Amin Mottahedin
MSc, PhD, FHEA
Senior Research Fellow
We (Buchan's lab and Foster's lab) investigate how time-of-day affects stroke-induced brain injury. I am particularly interested in how metabolic responses to ischemia and hypoxia are affected by time of day and our circadian rhythm.
I completed my PhD in Medical Sciences from University of Gothenburg (Mallard's lab). During my studies, we revealed the mechanisms by which bacterial and viral infections exacerbate neonatal hypoxic-ischemic brain injury. After receiving an international postdoc fellowship from Swedish Research Council, I joined Mike Murphy's & Thomas Krieg's lab at University of Cambridge, where we were able to identify malonate as a potential therapeutic to reduce ischemia-reperfusion injury after stroke.
Contact information
Colleges
Recent publications
Multifaceted Immune Effects of the Scavenger Receptor CD36 on Long-Term Outcomes After Neonatal Arterial Focal Stroke.
Journal article
Di Martino E. et al, (2026), J Neurochem, 170
Multimodal molecular profiling of the metabolic penumbra in hyperacute stroke
Preprint
Mottahedin A. et al, (2026)
Measuring cerebral glucose metabolism by chemical exchange-sensitive spin-lock (CESL) MRI of 2-deoxy-D-glucose in rodents.
Journal article
Boehm-Sturm P. et al, (2026), PLoS One, 21
2-deoxy-D-glucose chemical exchange-sensitive spin-lock MRI of cerebral glucose metabolism after transient focal stroke in the rat.
Journal article
Boehm-Sturm P. et al, (2025), J Cereb Blood Flow Metab, 45, 2370 - 2380
Local arterial administration of acidified malonate as an adjunct therapy to mechanical thrombectomy in ischemic stroke.
Journal article
Lee JJ. et al, (2025), Cardiovasc Res, 121, 1407 - 1418